John Wiley & Sons, Inc. (NYSE:WLYB – Get Free Report) saw unusually-strong trading volume on Monday . 4,411 shares were traded during trading, an increase of 134% from the previous session’s volume of 1,883 shares.The stock last traded at $48.50 and had previously closed at $46.68.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of John Wiley & Sons in a research note on Friday, July 17th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, John Wiley & Sons currently has an average rating of “Hold”.
Get Our Latest Stock Report on John Wiley & Sons
John Wiley & Sons Price Performance
John Wiley & Sons (NYSE:WLYB – Get Free Report) last issued its quarterly earnings results on Thursday, September 3rd. The company reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.04. The company had revenue of $386.36 million for the quarter, compared to the consensus estimate of $380.20 million. John Wiley & Sons had a net margin of 11.90% and a return on equity of 27.99%.
John Wiley & Sons Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, July 23rd. Stockholders of record on Tuesday, July 7th were given a dividend of $0.3575 per share. The ex-dividend date of this dividend was Tuesday, July 7th. This represents a $1.43 dividend on an annualized basis and a dividend yield of 3.0%. This is an increase from John Wiley & Sons’s previous quarterly dividend of $0.35. John Wiley & Sons’s payout ratio is currently 37.83%.
About John Wiley & Sons
John Wiley & Sons, Inc is a global publishing and knowledge-services company that develops content and learning solutions for researchers, students, educators, professionals and organizations. Its offerings include scholarly journals, academic books, reference materials, digital learning products, online courseware and professional development resources.
Wiley supports the research ecosystem by publishing scientific, technical, medical and scholarly content, as well as providing platforms and services that help researchers discover, access and share information.
Further Reading
- Five stocks we like better than John Wiley & Sons
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
- AMD Chips Away at NVIDIA’s AI Throne
- Is the Fed Playing Chess With Rates—Or Just Behind the Curve Again?
Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with MarketBeat.com's FREE daily email newsletter.
